NCT00332488

Brief Summary

to demonstrate the efficacy of inhaled Technosphere/Insulin in combination with metformin versus combination metformin and a secretagogue

Trial Health

98
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Strong global presence with extensive site network
Enrollment
547

participants targeted

Target at P50-P75 for phase_3 diabetes-mellitus-type-2

Geographic Reach
11 countries

120 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

December 1, 2004

Completed
1.5 years until next milestone

First Submitted

Initial submission to the registry

May 31, 2006

Completed
1 day until next milestone

First Posted

Study publicly available on registry

June 1, 2006

Completed
1.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2008

Completed
6.6 years until next milestone

Results Posted

Study results publicly available

October 16, 2014

Completed
Last Updated

October 16, 2014

Status Verified

October 1, 2014

Enrollment Period

3.2 years

First QC Date

May 31, 2006

Results QC Date

July 22, 2014

Last Update Submit

October 9, 2014

Conditions

Outcome Measures

Primary Outcomes (1)

  • Difference in Change From Baseline for HbA1c Between TI+ Metformin and Metformin+Secretagogue

    Baseline to Week 12

Secondary Outcomes (2)

  • Difference in Change From Baseline for HbA1c Between TI Alone and Metformin+Secretagogue

    Baseline to Week 12

  • Change in HbA1c From Baseline to Week 24 (Subjects Who Stayed on Original Treatment)

    Week 24

Study Arms (3)

1

EXPERIMENTAL

Technosphere Insulin

Drug: Technosphere Insulin

2

ACTIVE COMPARATOR

Metformin \& Secretagogues

Drug: Metformin & Secretagogues

3

EXPERIMENTAL

Technosphere \& Metformin

Drug: Technosphere Insulin & Metformin

Interventions

Inhalation, 15U/30U, prandial

1

Metformin tablets,Secretagogues supplied as any of the currently marketed brands and formulations.

2

Technosphere Insulin Inhalation Powder 15U/30U, Metformin tablets

3

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Non-smokers with clinical diagnosis of Type 2 diabetes mellitus for \>or= to 6 months
  • Stable regimen of metformin for \> or = to 1000mg/day or maximum tolerated dose) and a secretagogue \< or = 1/2 the maximum manufacturer-recommended daily dose without any dose adjustments within the preceding 6 wks.
  • HbA1c \>or= to 7.5% and \< or= to 11.0%
  • BMI \< or = to 40kg/m2.
  • FEV1\> or = to 70%, Total Lung capacity and \> or =80% DLco \> or= to 70%

You may not qualify if:

  • Treatment with any type of anti-diabetic therapy, other than metformin \& secretagogues within the preceding 12 weeks
  • Serum creatinine \> 1.4mg/dL in female subjects and \>1.5mg/dL in male subjects
  • History of chronic obstructive pulmonary disease, clinically proven asthma and/or any other clinically important pulmonary function testing and/or radiologic findings
  • Evidence of serious complications of diabetes (e.g. autonomic neuropathy)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (120)

Radiant Research-Birmingham

Birmingham, Alabama, 35209, United States

Location

Parkway Medical Center

Birmingham, Alabama, 35215, United States

Location

Redpoint Research

Phoenix, Arizona, 85029, United States

Location

Arizona Center for Clinical Research

Phoenix, Arizona, 85032, United States

Location

International Clinical Research Network

Chula Vista, California, 91911, United States

Location

National Jewish Medical & Research Center

Denver, Colorado, 80206, United States

Location

Creekside Endocrine Associates

Denver, Colorado, 80209, United States

Location

Jennifer Hone MD

Denver, Colorado, 80220, United States

Location

Chase Medical Research, LLC

Waterbury, Connecticut, 06708, United States

Location

Center for Diabetes & Endocrine Care

Hollywood, Florida, 33021, United States

Location

International Research Associates LLC

Miami, Florida, 33156, United States

Location

Cedar-Crosse Research Center

Chicago, Illinois, 60607, United States

Location

John H Stoger Jr Hospital of Cook County

Chicago, Illinois, 60612, United States

Location

Clintell Inc

Skokie, Illinois, 60076, United States

Location

James A Dicke MDPA

Towson, Maryland, 21204, United States

Location

East Coast Clinical Research Inc

Haverhill, Massachusetts, 01830, United States

Location

Wayne State University

Detroit, Michigan, 48201, United States

Location

Michigan Institute of Medicine

Livonia, Michigan, 48152, United States

Location

Washington University School of Medicine

St Louis, Missouri, 63110, United States

Location

Clayton Medical Research

St Louis, Missouri, 63117, United States

Location

Raidant Research-St Louis

St Louis, Missouri, 63141, United States

Location

Creighton Diabetes Center

Omaha, Nebraska, 68131, United States

Location

Lovelace Scientific Resources (Albuquerque)

Albuquerque, New Mexico, 87108, United States

Location

Winthrop University Hospital

Mineola, New York, 11501, United States

Location

North Shore Diabetes and Endocrine Associates

New Hyde Park, New York, 11042, United States

Location

Metrolina Internal Medicine

Charlotte, North Carolina, 28204, United States

Location

Charlotte Clinical Research Inc

Charlotte, North Carolina, 28211, United States

Location

Sensenbrenner Primary Care

Charlotte, North Carolina, 28277, United States

Location

Duke Medical Center

Durham, North Carolina, 27710, United States

Location

Dayton Clinical Research

Dayton, Ohio, 45406, United States

Location

Providence Health Partners - Center of Clinical Research

Dayton, Ohio, 45439, United States

Location

Radiant Research

Portland, Oregon, 97239, United States

Location

Upstate Pharmaceutical Research

Greenville, South Carolina, 29615, United States

Location

Collierville Medical Specialists

Collierville, Tennessee, 38017, United States

Location

Memphis Internal Medicine (Kathawala)

Memphis, Tennessee, 38119, United States

Location

GoodLife Medical Center PLLC

Memphis, Tennessee, 38120, United States

Location

Baylor Endocrine Center

Dallas, Texas, 75246, United States

Location

Quality Assurance Research Center Inc

San Antonio, Texas, 78205, United States

Location

Clinical Trials of Texas Inc

San Antonio, Texas, 78229, United States

Location

Covenant Clinic Research

San Antonio, Texas, 78229, United States

Location

Diabetes & Glandular Disease Research Assoc PA

San Antonio, Texas, 78229, United States

Location

SAM Clinical Research Center

San Antonio, Texas, 78229, United States

Location

Cedar Research

Tacoma, Washington, 98405, United States

Location

Hospital Interzonal de Agudos Pedro Fiorito

Avellaneda, Buenos Aires, B1870ARG, Argentina

Location

Centro Endocrinologic Tiempo

Buenos Aires, C1117ABH, Argentina

Location

Hospital Italiano de Buenos Aires

Buenos Aires, C1181ACH, Argentina

Location

Cons Asoc de Endocrinologia

Buenos Aires, C1425AGC, Argentina

Location

CIMeL

Buenos Aires, Argentina

Location

Hospital de Clinicas de Porto Alegre

Porto Alegre, Rio Grande do Sul, 90035-903, Brazil

Location

Hospital Sao Lucas da PUCRS

Porto Alegre, Rio Grande do Sul, 90610-000, Brazil

Location

Ccbr Brasil Centro de Analises e Pesquisas Clinicas Ltda

Rio de Janeiro, 22271-100, Brazil

Location

Hospital Guilherme Alvaro

Santos, 11045-904, Brazil

Location

CPClin-Centro de Pesquisas Clinicas

São Paulo, 01244-030, Brazil

Location

UNIFRSP

São Paulo, 04020-050, Brazil

Location

Hospital do Rim e Hipertensao

São Paulo, 04025-011, Brazil

Location

Instituto de Pesquisa Clinica e Medicina Avancada

São Paulo, 05437-010, Brazil

Location

Quest Clinical Trials

Markham, Ontario, L6B 1A1, Canada

Location

Lifestyle Metabolism Center

Oakville, Ontario, L6H 3P1, Canada

Location

Lifestyle Metabolism Center

Thornhill, Ontario, L4J 8L7, Canada

Location

Lifestyle Metabolism Center

Toronto, Ontario, M4R 2G4, Canada

Location

Trial Management Group Inc (Henein

Toronto, Ontario, M4T 1N5, Canada

Location

Unimedico Management

Richmond Hill, L4C 9M7, Canada

Location

Hospital Padre Alberto Hurtado

Santiago, Santiago Metropolitan, Chile

Location

Hospital Clinico Pontificia Universidad Catolica de Chile

Santiago, Chile

Location

Hospital del Salvador

Santiago, Chile

Location

Instituto de Informacion de Tramiento y Educacion en Salud

Santiago, Chile

Location

Diabetologicka a interni ambulance

Ostrava-Kunčice, CZE, 70702, Czechia

Location

Institute for Clinical and Exp Medicine

Prague, CZE, 140 21, Czechia

Location

University Hospital Na Bulovce

Prague, CZE, 180 81, Czechia

Location

Interní a diabetologická Outpatient

Ostrava, Ostrava, 70900, Czechia

Location

Diabetologicka ambulance (Chmura)

Ostrava, 70200, Czechia

Location

II interni klinika FN Kralovske Vinohrady

Prague, 10034, Czechia

Location

Endokrinologicky ustav

Prague, 11694, Czechia

Location

3rd Medical Department General Faculty Hospital

Prague, 12801, Czechia

Location

Instituto Mexicano de Investigacion

Mexico City, Durango, 06700, Mexico

Location

Hospital Universitario Dr Jose E Gonzalez

Monterrey, Nuevo León, 64460, Mexico

Location

Hospital Santa Engracia-CIMA

Garza García, 66260, Mexico

Location

Centro de Estudios en Diabetes

Mexico City, 01120, Mexico

Location

Hospital General de Mexico Servicio EndocrinologiaJefe Del Servicio

Mexico City, 06726, Mexico

Location

OCA-MIRC

Monterrey, 64020, Mexico

Location

Klinika Endocrinologii Diabetologii I

Bialystock, POL, 15-276, Poland

Location

NZOZ Specjalistyczny Osrodek Internistyczno - Diabetologiczny

Bialystok, POL, 15-435, Poland

Location

Katedra I Klinika Chorob Metabolicznych Collegium Medicum Uniwersytety Jagiellonskiego

Krakow, POL, 31 501, Poland

Location

Instytut Centrum Zdrowia (009) Matki Polki

Lodz, POL, 93-338, Poland

Location

Spzital Kolejowy imm Wlodzimierza Roeflera

Pruszków, POL, 05-800, Poland

Location

Oddzial Kliniczny Diabetologii (009) Kliniczny nr 1 im Norberta Barlickiego Uniwersytety Meycznego

Lodz, 90-153, Poland

Location

Centrum Leczenia Chorob cywilizacyjnych

Warsaw, 02 777, Poland

Location

Niepubliczny Zaklad Opieki Zdrowotnej VIVAMED

Warsaw, 03 580, Poland

Location

NHI Kemerovo Regional Clinical Hospital

Kemerovo, RUS, 650061, Russia

Location

NI Principal Military Clinical Hospital n a academician N.N. Burdenko of the Ministry of Defense

Moscow, RUS, 105229, Russia

Location

NEI HPE Moscow State University of Medicine and Dentistry of FAHSD City Clinical Hospital #70

Moscow, RUS, 111399, Russia

Location

NI Endrocrinological Research Centre of RAMS In patient replacing technologies department

Moscow, RUS, 115478, Russia

Location

NI Moscow Regional Scientific Research Clinical Institute na MF Vladimirsky

Moscow, RUS, 129110, Russia

Location

St Petersburg NHI City Polytclinic #77 City Diabetological Center #4

Saint Petersburg, RUS, 193012, Russia

Location

Central Medical Sanitary Unit #122

Saint Petersburg, RUS, 194291, Russia

Location

St Petersburg NHI Municipal Multi-Speciality Hospital # 2

Saint Petersburg, RUS, 194354, Russia

Location

TUV Medico-Military Academy

Saint Petersburg, RUS, 198013, Russia

Location

NEI HPE Smolensk State Medical Academy of FAHSD RNHI Smolensk Regional Clinical Hospital

Smolensk, RUS, 214018, Russia

Location

MHI Clinical Hospital for Emergency Care na NV Soloviev

Yaroslavl, RUS, 150003, Russia

Location

NHI Yaroslavl Regional Clinical Hospital

Yaroslavl, RUS, 150062, Russia

Location

NI Central Clinical Hospital of RAS

Moscow, 117 593, Russia

Location

Complejo Hospitalario Nuestra Senora de Valme

Seville, Andalusia, 41014, Spain

Location

Hospital Clinic I Provincial

Barcelona, 08036, Spain

Location

Hospital Universitario de la Princessa

Madrid, 28006, Spain

Location

Hospital Ramon y Cajal

Madrid, 28034, Spain

Location

Corporacion Sanitaria Parc Tauli Unidad de Endocrinologia

Sabadell, 08208, Spain

Location

Bukovinian State Medical University Dept of Clinical Immun

Chernivtsy, UKR, 58022, Ukraine

Location

Dniepropetrovsh State Medical Academy

Dniepropetrovsk, UKR, 49023, Ukraine

Location

Donetsk State Medical University

Donetsk, UKR, 83003, Ukraine

Location

Donetsk State Medical University (Chair of Immun Allergogoly & Endocrin)

Donetsk, UKR, 83099, Ukraine

Location

Railway Clinical Hospital on Donetsk Station

Donetsk, UKR, 83114, Ukraine

Location

Chair Family Med of National Med University

Kiev, UKR, 04050, Ukraine

Location

Institute of Endocrinology and Metabolism

Kiev, UKR, 04114, Ukraine

Location

Ukr Scientifically Practical Centre of Endocrine Surgery

Kiev, UKR, 2175, Ukraine

Location

Odessa State Medical University Dept of Gen Practice and Med Rehab

Odesa, UKR, 65009, Ukraine

Location

Odessa Reg. Clinical Hosp Outpatient Department

Odesa, UKR, 65025, Ukraine

Location

Odessa State Med Dept of Family Med and Gen Practice

Odesa, UKR, 65039, Ukraine

Location

Vinnitsa State Medical University

Vinnitsa, UKR, 21010, Ukraine

Location

Outpatient Clinic of Family Physician "Rusanovka"

Kiev, 02147, Ukraine

Location

Public Institution City Policlinic #20 Odessa

Odesa, 65114, Ukraine

Location

MeSH Terms

Conditions

Diabetes Mellitus, Type 2

Interventions

MetforminSecretagogues

Condition Hierarchy (Ancestors)

Diabetes MellitusGlucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesEndocrine System Diseases

Intervention Hierarchy (Ancestors)

BiguanidesGuanidinesAmidinesOrganic ChemicalsPhysiological Effects of DrugsPharmacologic ActionsChemical Actions and Uses

Limitations and Caveats

Wks 12-24 was a non-randomized treatment period of the trial; outcomes were not analyzed for Wks 12-24. Safety results include entire trial; patients counted in multiple treatments for safety.

Results Point of Contact

Title
Chief Medical Officer
Organization
MannKind Corporation

Study Officials

  • For MannKind sponsored trials, the Overall Study Official is the Chief Scientific Officer

    Mannkind Corporation

    STUDY DIRECTOR

Publication Agreements

PI is Sponsor Employee
No
Restriction Type
OTHER
Restrictive Agreement
Yes

Study Design

Study Type
interventional
Phase
phase 3
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
CROSSOVER
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 31, 2006

First Posted

June 1, 2006

Study Start

December 1, 2004

Primary Completion

March 1, 2008

Last Updated

October 16, 2014

Results First Posted

October 16, 2014

Record last verified: 2014-10

Locations